Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Kromek swells ranks of tech sector with £55mln AIM float

The tech sector has a new addition with Kromek Group making its debut on the junior market having raised £15mln in new investment that will fund its continued development. The new issue, at 51p a share, which values the group at £55mln, was oversubscribed.
Kromek swells ranks of tech sector with £55mln AIM float

The tech sector has a new addition with Kromek Group (LON: KMK) making its debut on the junior market having raised £15mln in new investment that will fund its continued development.

The new shares were issued at 51p a share, which values the group at £55mln, and the issue was oversubscribed.

The business is at the cutting-edge of x-ray technology and has developed products with cadmium zinc telluride (CZT) family of materials at their core.

Recognised as the premier components for digital and spectral radiation detectors, CZT compounds proved very difficult to produce in a commercially viable way.

Kromek’s technique has overcome these limitations based on research by Durham’s physics department.

Its CZT-based products provide high resolution information on material composition and structure, and they are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Kromek chief executive Arnab Basu said: "We are delighted with our oversubscribed fundraising.

“After many years developing the business and our technology, Kromek is ready to begin harvesting value by seizing the opportunities to sell our technology and products into the medical imaging, security screening and nuclear detection markets.”

The proceeds from the initial public offering (IPO) will be used for product development, expansion of the sales and marketing team and investment into the company's intellectual property portfolio as well as paying down certain loans, the firm said.

The Kromek IPO is also a boon for Amphion Innovations (LON:AMP), the intellectual property group that has partnered the County Durham-based tech success story through its formative years.

Ampion has an 11.6% stake, which at the listing price, is worth £6.4mln. This is more than its current market capitalisation.

Amphion chief executive Richard Morgan said: "We are pleased Kromek has completed a successful listing on AIM and has raised the capital required to support its commercial targets.

“This is an exciting point in Kromek's development as it has substantial opportunities for growth.

“The listing and new capital will be important in securing further contracts for its leading technology in the medical imaging, security screening, and nuclear detection markets."


View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

x-ray image
September 04 2017
The radiation detection specialist is expecting revenues to grow by at least 40% this year after spending a couple of years laying the foundations
Tekcapital-Invention-Discovery-Network-(IDN)-June-2015_opt.jpg
July 31 2017
The firm has established connections with more than 4,000 universities in 160 countries enabling it to capture all of the intellectual property available
VW-plant.jpg
October 10 2017
Mike McAuliffe reckons the company's technology is 'tremendous', it is just a case of making the most of it commercially

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use